EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A WHO 2021‐based comprehensive scheme outlining sperm parameters’ associations with IVF outcomes in PGT‐A cycles

Rossella Mazzilli, Danilo Cimadomo, Federica Innocenti, Marilena Taggi, Greta Chiara Cermisoni, Sara Ginesi, Lisa Dovere, Laura Albricci, Maurizio Guido, Maria Rosaria Campitiello, Susanna Ferrero, Antonio Capalbo iD und 5 weitere

Andrology · 2025

DOI: 10.1111/andr.13811 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Andrology, 2025. Verfasst von Rossella Mazzilli und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Molecular Medicine, University "Sapienza" of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Aneuploidy, Preimplantation Diagnosis, Fertilization in Vitro, Semen Analysis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To examine the association between semen parameters, assessed according to World Health Organization (WHO)‐2021 criteria, and paternal body mass index (BMI) and age, with embryological and clinical outcomes in ICSI cycles involving preimplantation genetic testing for aneuploidy (PGT‐A).

Design

Retrospective study at a private in vitro fertilization (IVF) clinic. Subjects 3101 couples undergoing 4013 intracytoplasmic sperm injection (ICSI) + PGT‐A cycles with own‐oocytes (years 2013–2021).

Intervention

We performed trophectoderm biopsy, and comprehensive chromosome testing to report uniform aneuploidies and vitrified‐warmed euploid single‐blastocyst‐transfers. Regression analyses adjusted for relevant confounders were conducted to outline putative associations of semen analysis and characteristics and paternal BMI and age with all embryological/clinical outcomes.

Results

Maternal age was the only significant confounding variable affecting euploidy blastocyst rate (EBR) (primary embryological outcome). When categorized, motility < 5 th ‐percentile (‐2.5%, 95%CI ‐4.9 to ‐0.2%, p = 0.03), concentration plus morphology < 5 th ‐percentile (‐2.7%,95%CI ‐4.8 to ‐0.6%, p = 0.01), concentration plus morphology plus motility < 5 th ‐percentile (‐4.0%,95%CI ‐5.5 to ‐2.6%, p < 0.01), obstructive‐azoospermia [OA] (‐5.5%,95%CI ‐9 to ‐2%, p = 0.02) and non‐obstructive azoospermia (NOA) (‐5.8%,95%CI ‐10.9 to ‐0.6%, p = 0.03) showed significantly lower results compared to all parameters > 5 th ‐percentile. Furthermore, after adjusting for maternal age and the number of metaphase‐II‐oocytes inseminated, the only significant confounding variable affecting the chance of obtaining ≥ 1 live birth among completed cycles (primary clinical outcome) was basal and post sperm processing motility. When categorized, concentration plus morphology plus motility < 5 th ‐percentile (multivariable‐OR: 0.73, 95%CI 0.58–0.93, p = 0.01) and OA (multivariable‐OR: 0.47, 95%CI 0.24–0.92, p = 0.03) showed significantly lower chances compared to all parameters > 5 th ‐percentile. Advanced paternal age (defined as > 44 years) was associated only with lower day 5‐blastocyst and Gardner's AA‐grade (i.e., top quality) blastocyst rates.

Conclusions

This comprehensive analysis provides IVF professionals with useful figures to counsel infertile couples about their chances of success, taking into account the impact of semen characteristics and paternal BMI and age. These estimates are valuable for personalized decision‐making about the most effective reproductive strategies to adopt, especially not underestimating male factor, by improving sperm concentration and motility whenever possible before assisted reproductive technologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AneuploidyPreimplantation DiagnosisFertilization in VitroSemen AnalysisSpermatozoaHumansMaleRetrospective StudiesFemaleAdultPregnancySperm Injections, IntracytoplasmicWorld Health OrganizationMaternal AgeSperm MotilityGenetic TestingPregnancy RateBody Mass Index

Stichwörter der Autor:innen

ICSIPGT‐Acumulative live birth ratepaternal agesperm factor

Autor:innen und Institutionen

  • Department of Clinical and Molecular Medicine, University "Sapienza" of Rome, Rome, Italy.
  • IVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Rome, Italy.
  • Department of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia, Italy.
  • Department of Clinical Medicine, Public Health, Life Sciences and the Environment, University of L'Aquila, L'Aquila, Italy.
  • Department of Obstetrics and Gynecology and Physiopathology of Human Reproduction, ASL Salerno, Salerno, Italy.
  • Juno Genetics, Rome, Italy.

ORCID-Profile: Antonio Capalbo, Alberto Ferlin

Zitieren

APA

Mazzilli, R., Cimadomo, D., Innocenti, F., Taggi, M., Cermisoni, G. C., Ginesi, S., Dovere, L., Albricci, L., Guido, M., Campitiello, M. R., Ferrero, S., Capalbo, A., Vaiarelli, A., Ubaldi, F. M., Ferlin, A., Rienzi, L., & Gennarelli, G. (2025). A WHO 2021‐based comprehensive scheme outlining sperm parameters’ associations with IVF outcomes in PGT‐A cycles. Andrology. https://doi.org/10.1111/andr.13811

Vancouver

Mazzilli R, Cimadomo D, Innocenti F, Taggi M, Cermisoni GC, Ginesi S, et al. A WHO 2021‐based comprehensive scheme outlining sperm parameters’ associations with IVF outcomes in PGT‐A cycles. Andrology. 2025. doi:10.1111/andr.13811

BibTeX
@article{Mazzilli2025,
  author = {Mazzilli, Rossella and Cimadomo, Danilo and Innocenti, Federica and Taggi, Marilena and Cermisoni, Greta Chiara and Ginesi, Sara and Dovere, Lisa and Albricci, Laura and Guido, Maurizio and Campitiello, Maria Rosaria and Ferrero, Susanna and Capalbo, Antonio and Vaiarelli, Alberto and Ubaldi, Filippo Maria and Ferlin, Alberto and Rienzi, Laura and Gennarelli, Gianluca},
  title = {A WHO 2021‐based comprehensive scheme outlining sperm parameters’ associations with IVF outcomes in PGT‐A cycles},
  journal = {Andrology},
  year = {2025},
  doi = {10.1111/andr.13811}
}
Kostenlos starten →